MedTrace Logo

A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation Year

NCT02143479 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 398

Last updated 2024-10-21

No results posted yet for this study

Summary

A study in which two groups of patients will be analysed; patients converted from Prograf to Advagraf within the first 3 months after transplantation and patients converted from Prograf to Advagraf between 3 months and 1 year after transplantation.

Conditions

  • Liver Transplantation

Interventions

DRUG

Tacrolimus

oral

Sponsors & Collaborators

  • Astellas Pharma S.A.S.

    lead INDUSTRY

Principal Investigators

  • Medical and Scientific Affairs Manager, Transplantation · Astellas Pharma S.A.S.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-18
Primary Completion
2017-05-03
Completion
2017-05-03

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02143479 on ClinicalTrials.gov